Tapewire

Nasdaq · USD

ENTA

ENANTA PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
5673
SEC CIK
0001177648
Parsed reports
332

Last 12 months

Inside the activity.

0 purchase rows · 9 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202509
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 20, 2015 Filed Nov 22, 2016 23:57 UTC Amendment
Ocain TimSenior Vice President
GrantStock Option (right to buy) · Derivative 25,500 $0.00 Strike: $31.42 $0.00
Disclosure

SEC source: 0001177648-16-000027 · edgar.xml · derivative · entry 1

Ocain Tim · CIK 0001599020 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,500

Underlying: Common Stock · 25,500 shares

Expires 2025-11-20

F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2015).

F2 · derivative.expiration_date: This Form 4 is being amended to correct the original Form 4 filing by amending the expiration date of the granted stock option from "11/20/2014" to "11/20/2025". This amendment corrects an administrative error.

Read SEC document
November 20, 2014 Filed Nov 22, 2016 23:45 UTC Amendment
Ocain TimSenior Vice President
GrantStock Option (right to buy) · Derivative 27,500 $0.00 Strike: $44.00 $0.00
Disclosure

SEC source: 0001177648-16-000022 · edgar.xml · derivative · entry 1

Ocain Tim · CIK 0001599020 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,500

Underlying: Common Stock · 27,500 shares

Expires 2024-11-20

F1 · derivative.exercise_date: Such option will become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2014).

F2 · derivative.expiration_date: This Form 4 is being amended to correct the original Form 4 filing by amending the expiration date of the granted stock option from "11/20/2014" to "11/20/2024". This amendment corrects an administrative error.

Read SEC document
January 30, 2014 Filed Oct 2, 2018 20:21 UTC Amendment
Ocain TimSenior Vice President
GrantStock Option (right to buy) · Derivative 70,000 $0.00 Strike: $32.27 $0.00
Disclosure

SEC source: 0001177648-18-000037 · edgar.xml · derivative · entry 1

Ocain Tim · CIK 0001599020 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2024-01-30

F1 · derivative.exercise_price: This amendment is being filed to correct the original Form 4 filing by amending the conversion or exercise price of the derivative security reported in column 2 from "$32.43" to "$32.27". This amendment corrects an administrative error.

F2 · derivative.exercise_date: 25% of the shares subject to the option will vest on the first anniversary of January 30, 2014 (the "Commencement Date"), and the remaining shares will vest in twelve (12) successive and equal quarterly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Commencement Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.